Amy Jo Sterling

Array ( [id] => 6571252 [patent_doc_number] => 20020165380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'DNA encoding a mammalian receptor (fb41a) and uses thereof' [patent_app_type] => new [patent_app_number] => 09/925922 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22601 [patent_no_of_claims] => 140 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165380.pdf [firstpage_image] =>[orig_patent_app_number] => 09925922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6621865 [patent_doc_number] => 20020065217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Treatments which elevate functional glycosylated leptin transport factor, for controlling weight and obesity' [patent_app_type] => new [patent_app_number] => 09/922450 [patent_app_country] => US [patent_app_date] => 2001-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12160 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065217.pdf [firstpage_image] =>[orig_patent_app_number] => 09922450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817661 [patent_doc_number] => 20030068619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'TNF receptor 2 related protein variant' [patent_app_type] => new [patent_app_number] => 09/917372 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16905 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068619.pdf [firstpage_image] =>[orig_patent_app_number] => 09917372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560288 [patent_doc_number] => 20020164689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Class II cytokine receptor-like proteins and nucleic acids encoding them' [patent_app_type] => new [patent_app_number] => 09/912672 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 34121 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164689.pdf [firstpage_image] =>[orig_patent_app_number] => 09912672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985049 [patent_doc_number] => 20020098163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Human tumor necrosis factor receptors TR21 and TR22' [patent_app_type] => new [patent_app_number] => 09/910562 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 87276 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098163.pdf [firstpage_image] =>[orig_patent_app_number] => 09910562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786986 [patent_doc_number] => 20020160375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Human Patched genes and proteins, and uses related thereto' [patent_app_type] => new [patent_app_number] => 09/909280 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28385 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160375.pdf [firstpage_image] =>[orig_patent_app_number] => 09909280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381076 [patent_doc_number] => 20020119924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Combination therapy using a TNF binding protein for treating TNF-mediated diseases' [patent_app_type] => new [patent_app_number] => 09/907263 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22321 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119924.pdf [firstpage_image] =>[orig_patent_app_number] => 09907263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048607 [patent_doc_number] => 20020169118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'TNF receptors, TNF binding proteins and DNAs coding for them' [patent_app_type] => new [patent_app_number] => 09/899429 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24560 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169118.pdf [firstpage_image] =>[orig_patent_app_number] => 09899429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 411681 [patent_doc_number] => 07282483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF' [patent_app_type] => utility [patent_app_number] => 09/898234 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 24840 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282483.pdf [firstpage_image] =>[orig_patent_app_number] => 09898234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968206 [patent_doc_number] => 20020090676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'TNF receptors, TNF binding proteins and DNAs coding for them' [patent_app_type] => new [patent_app_number] => 09/899422 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24594 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090676.pdf [firstpage_image] =>[orig_patent_app_number] => 09899422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658601 [patent_doc_number] => 20030078405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => '47 human secreted proteins' [patent_app_type] => new [patent_app_number] => 09/895298 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 131464 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078405.pdf [firstpage_image] =>[orig_patent_app_number] => 09895298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275851 [patent_doc_number] => 20020106655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Human GPCR proteins' [patent_app_type] => new [patent_app_number] => 09/895686 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106655.pdf [firstpage_image] =>[orig_patent_app_number] => 09895686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625617 [patent_doc_number] => 06723552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/885478 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 35789 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723552.pdf [firstpage_image] =>[orig_patent_app_number] => 09885478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 784929 [patent_doc_number] => 06989147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-24 [patent_title] => 'Truncated soluble tumor necrosis factor type-I and type-II receptors' [patent_app_type] => utility [patent_app_number] => 09/882735 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 37940 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/989/06989147.pdf [firstpage_image] =>[orig_patent_app_number] => 09882735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292374 [patent_doc_number] => 20020055625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Members of TNF and TNFR families' [patent_app_type] => new [patent_app_number] => 09/877156 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19864 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055625.pdf [firstpage_image] =>[orig_patent_app_number] => 09877156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048606 [patent_doc_number] => 20020169117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Ligand for receptor activator of NF-kappaB' [patent_app_type] => new [patent_app_number] => 09/877650 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16352 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169117.pdf [firstpage_image] =>[orig_patent_app_number] => 09877650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715457 [patent_doc_number] => 20030026805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Biological products' [patent_app_type] => new [patent_app_number] => 09/875221 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16817 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20030026805.pdf [firstpage_image] =>[orig_patent_app_number] => 09875221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809095 [patent_doc_number] => 20030199034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/156846 [patent_app_country] => US [patent_app_date] => 2001-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63490 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199034.pdf [firstpage_image] =>[orig_patent_app_number] => 10156846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179704 [patent_doc_number] => 06740522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Antibodies against ligand for receptor activator of NF-kB' [patent_app_type] => B2 [patent_app_number] => 09/865363 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19314 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740522.pdf [firstpage_image] =>[orig_patent_app_number] => 09865363 [rel_patent_id] =>[rel_patent_doc_number] =>)